The NGAL Test is a particle-enhanced turbidimetric immunoassay for the quantitative determination of NGAL in human urine and plasma on automated clinical chemistry analyzers. NGAL measurements are useful in the risk assesment of AKI.
NGAL - Bioporto
Bioporto har sendt svar til amerikanske myndigheder om NGAL-test — MedWatch
BioPorto Diagnostics A/S
Clonezyme Biotek
Plasma orexin A does not reflect severity of illness in the intensive care units patients with systemic inflammation, JA Clinical Reports
/wp-content/uploads/2019/11/Lab.jpg
NGAL ELISA Kit (human) - Bioporto
PDF) Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
Neutrophil Gelatinase-Associated Lipocalin in Cancer - ScienceDirect
First Acute Kidney Injury Diagnostic Test Wins FDA Clearance - Research Horizons
May Neutrophil Gelatinase-Associated Lipocalin (NGAL) Level Predict Mortality in Patients with Hepatocellular Carcinoma (HCC)?
News - Bioporto
